Perrigo Announces Executive Transition for its Consumer Self-Care International (CSCI) BusinessPRNewsWire • 05/07/24
Insights Into Perrigo (PRGO) Q1: Wall Street Projections for Key MetricsZacks Investment Research • 05/06/24
Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 MillionPRNewsWire • 04/25/24
CVS Caremark to cover Perrigo's birth control pill in US at zero cost for plan sponsorsReuters • 04/04/24
Perrigo Commences Shipments of Opill® to Retailers Nationwide, Empowering Millions to Enter a New Era of Reproductive Health Access in the United StatesPRNewsWire • 03/04/24
Compared to Estimates, Perrigo (PRGO) Q4 Earnings: A Look at Key MetricsZacks Investment Research • 02/27/24
Perrigo Reports Fourth Quarter & Fiscal Year 2023 Financial Results From Continuing Operations; Launches Investment & Efficiency ProgramPRNewsWire • 02/27/24
Ahead of Perrigo (PRGO) Q4 Earnings: Get Ready With Wall Street Estimates for Key MetricsZacks Investment Research • 02/26/24
Perrigo to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 27, 2024PRNewsWire • 02/13/24
Perrigo (PRGO) Up 2% Since Last Earnings Report: Can It Continue?Zacks Investment Research • 12/07/23